Regulus Therapeutics
RGLS
#6991
Rank
ยฃ0.41 B
Marketcap
ยฃ6.03
Share price
0.00%
Change (1 day)
397.58%
Change (1 year)

Earnings for Regulus Therapeutics (RGLS)

Earnings in 2025 (TTM): -ยฃ36.82 Million

According to Regulus Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ34.17 Million a decrease over its 2023 earnings that were of -ยฃ21.77 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regulus Therapeutics from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ36.82 Million7.76%
2024 -ยฃ34.17 Million56.97%
2023 -ยฃ21.77 Million6.51%
2022 -ยฃ20.44 Million2.53%
2021 -ยฃ19.93 Million93.59%
2020 -ยฃ10.3 Million-15.41%
2019 -ยฃ12.18 Million-64.46%
2018 -ยฃ34.24 Million-33.26%
2017 -ยฃ51.31 Million-13.98%
2016 -ยฃ59.65 Million44.77%
2015 -ยฃ41.2 Million-1.63%
2014 -ยฃ41.89 Million203.6%
2013 -ยฃ13.8 Million8.65%
2012 -ยฃ12.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
GlaxoSmithKline
GSK
ยฃ6.89 B-19,756.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
ยฃ6.72 B-19,287.12%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
ยฃ1.40 B-4,114.42%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ9.67 B-27,699.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
ยฃ96.36 M-374.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-ยฃ80.63 Million 129.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ5.94 B-17,036.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-ยฃ87 Million 148.06%๐Ÿ‡บ๐Ÿ‡ธ USA